Entera Bio Ltd.
ENTX
$1.22
$0.021.67%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -36.54% | -27.91% | -5.93% | -23.82% | -27.27% |
| Total Depreciation and Amortization | -12.50% | -36.36% | -27.27% | -36.36% | -38.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.00% | 28.21% | -3.33% | -10.46% | 31.87% |
| Change in Net Operating Assets | -148.65% | 44.41% | -177.63% | 136.41% | 277.32% |
| Cash from Operations | -120.09% | -24.95% | -16.16% | -22.17% | 24.60% |
| Capital Expenditure | -- | -800.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -800.00% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.04% | -95.06% | 1,830.77% | -98.06% | 44,976.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -- | -294.74% | -- |
| Cash from Financing | -99.03% | -94.59% | 1,823.08% | -104.19% | 44,356.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -124.79% | -196.11% | -5.84% | -1,337.82% | 750.93% |